Role of Virus-Induced Host Cell Epigenetic Changes in Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Aug 7

PMID 34361112

Citations 24

Authors

Valeria Pietropaolo

Carla Prezioso

Ugo Moens

Affiliations

Soon will be listed here.

Abstract

The tumor viruses human T-lymphotropic virus 1 (HTLV-1), hepatitis C virus (HCV), Merkel cell polyomavirus (MCPyV), high-risk human papillomaviruses (HR-HPVs), Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpes virus (KSHV) and hepatitis B virus (HBV) account for approximately 15% of all human cancers. Although the oncoproteins of these tumor viruses display no sequence similarity to one another, they use the same mechanisms to convey cancer hallmarks on the infected cell. Perturbed gene expression is one of the underlying mechanisms to induce cancer hallmarks. Epigenetic processes, including DNA methylation, histone modification and chromatin remodeling, microRNA, long noncoding RNA, and circular RNA affect gene expression without introducing changes in the DNA sequence. Increasing evidence demonstrates that oncoviruses cause epigenetic modifications, which play a pivotal role in carcinogenesis. In this review, recent advances in the role of host cell epigenetic changes in virus-induced cancers are summarized.

Citing Articles

Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics.

Zhang L, Duan X, Zhao Y, Zhang D, Zhang Y Front Immunol. 2025; 16:1526589.

PMID: 39995663 PMC: 11847830. DOI: 10.3389/fimmu.2025.1526589.

Epigenetic and epitranscriptomic regulation during oncogenic -herpesvirus infection.

Singh R, Vangala R, Torne A, Bose D, Robertson E Front Microbiol. 2025; 15:1484455.

PMID: 39839102 PMC: 11747046. DOI: 10.3389/fmicb.2024.1484455.

The interplay of EBV virus and cell metabolism in lung cancer.

Wang H J Cell Mol Med. 2024; 28(22):e70088.

PMID: 39601114 PMC: 11599874. DOI: 10.1111/jcmm.70088.

EZH2 Inhibition by DS3201 Triggers the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma Cells.

Gonnella R, Collura F, Corrado V, Di Crosta M, Santarelli R, Cirone M Viruses. 2024; 16(9).

PMID: 39339966 PMC: 11437442. DOI: 10.3390/v16091490.

An In-Depth Approach to the Associations between MicroRNAs and Viral Load in Patients with Chronic Hepatitis B-A Systematic Review and Meta-Analysis.

Manea M, Maruntelu I, Constantinescu I Int J Mol Sci. 2024; 25(15).

PMID: 39125978 PMC: 11313658. DOI: 10.3390/ijms25158410.

References

Haag T, Richter A, Schneider M, Jimenez A, Dammann R . The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms. BMC Cancer. 2016; 16:49. PMC: 4736155. DOI: 10.1186/s12885-016-2087-6. View

Liu J, Zhang X, Yan M, Li H . Emerging Role of Circular RNAs in Cancer. Front Oncol. 2020; 10:663. PMC: 7326090. DOI: 10.3389/fonc.2020.00663. View

DU Y, Kong G, You X, Zhang S, Zhang T, Gao Y . Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012; 287(31):26302-11. PMC: 3406714. DOI: 10.1074/jbc.M112.342113. View

Sartorius K, An P, Winkler C, Chuturgoon A, Li X, Makarova J . The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Front Immunol. 2021; 12:661204. PMC: 8117219. DOI: 10.3389/fimmu.2021.661204. View

Li B, Carey M, Workman J . The role of chromatin during transcription. Cell. 2007; 128(4):707-19. DOI: 10.1016/j.cell.2007.01.015. View

Fan H, Zhang H, Pascuzzi P, Andrisani O . Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. Oncogene. 2015; 35(6):715-26. PMC: 4615262. DOI: 10.1038/onc.2015.122. View

Konstatinell A, Coucheron D, Sveinbjornsson B, Moens U . MicroRNAs as Potential Biomarkers in Merkel Cell Carcinoma. Int J Mol Sci. 2018; 19(7). PMC: 6073391. DOI: 10.3390/ijms19071873. View

Bui T, Mendell J . Myc: Maestro of MicroRNAs. Genes Cancer. 2010; 1(6):568-575. PMC: 2946068. DOI: 10.1177/1947601910377491. View

Chang M, Uozaki H, Chong J, Ushiku T, Sakuma K, Ishikawa S . CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res. 2006; 12(10):2995-3002. DOI: 10.1158/1078-0432.CCR-05-1601. View

10.

Emmett S, Whiteman D, Panizza B, Antonsson A . An Update on Cellular MicroRNA Expression in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma. Oncology. 2018; 95(4):193-201. DOI: 10.1159/000489786. View

11.

Soejima K, Fang W, Rollins B . DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene. 2003; 22(30):4723-33. DOI: 10.1038/sj.onc.1206510. View

12.

Yang L, He J, Chen L, Wang G . Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells. Med Oncol. 2008; 26(4):445-51. DOI: 10.1007/s12032-008-9144-1. View

13.

Patel D, Huang S, Baglia L, McCance D . The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 1999; 18(18):5061-72. PMC: 1171577. DOI: 10.1093/emboj/18.18.5061. View

14.

Oura K, Morishita A, Masaki T . Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci. 2020; 21(21). PMC: 7664704. DOI: 10.3390/ijms21218362. View

15.

Improta G, Ritter C, Pettinato A, Vasta V, Schrama D, Fraggetta F . MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo. J Cancer Res Clin Oncol. 2017; 143(8):1489-1497. DOI: 10.1007/s00432-017-2413-7. View

16.

Qian K, Pietila T, Ronty M, Michon F, Frilander M, Ritari J . Identification and validation of human papillomavirus encoded microRNAs. PLoS One. 2013; 8(7):e70202. PMC: 3728184. DOI: 10.1371/journal.pone.0070202. View

17.

Carnero E, Barriocanal M, Prior C, Unfried J, Segura V, Guruceaga E . Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication. EMBO Rep. 2016; 17(7):1013-28. PMC: 4931568. DOI: 10.15252/embr.201541763. View

18.

Lan R, Wang Q . Deciphering structure, function and mechanism of lysine acetyltransferase HBO1 in protein acetylation, transcription regulation, DNA replication and its oncogenic properties in cancer. Cell Mol Life Sci. 2019; 77(4):637-649. PMC: 11104888. DOI: 10.1007/s00018-019-03296-x. View

19.

Chen T, Dent S . Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet. 2013; 15(2):93-106. PMC: 3999985. DOI: 10.1038/nrg3607. View

20.

Toberer F, Haenssle H, Heinzel-Gutenbrunner M, Enk A, Hartschuh W, Helmbold P . Metabolic reprogramming and angiogenesis in primary cutaneous Merkel cell carcinoma: expression of hypoxia-inducible factor-1α and its central downstream factors. J Eur Acad Dermatol Venereol. 2020; 35(1):88-94. DOI: 10.1111/jdv.16600. View